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Otomycosis usually develops in hot humid climates, and patients with otomycosis generally show a good
response to medical treatment. However, invasive otomycosis is rarely observed in immunocompetent
patients. The predisposing factors for invasive otomycosis include malignant neoplasms and increased
use of steroids and broad-spectrum antibiotics. We report a unique case of iatrogenic invasive otomycosis
in a 35-year-old woman who had been given oﬂoxacin eardrops over a long period, which led to an
invasive fungal infection. The patient showed no response to general antifungal agents, but the infection
was successfully controlled with voriconazole.
Copyright  2011, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Otomycosis is commonly observed in otolaryngology practice. In
this disease, themost common fungal species isolated in culture are
Aspergillus and Candida. However, cultures of the discharge are not
routinely obtained because the condition is rapidly responsive to
treatment with topical antifungal agents. An erroneous diagnosis of
otomycosis and lack of caution in the administration of ototopical
antibiotics may change the normal acidic environment of the
external ear canal and the clinical process of otomycosis.2. Case report
A 35-year-old woman with a history of right otalgia and head-
ache for 2 months visited our otolaryngology clinic. She had
developed right otalgia after an episode of acute pharyngitis and
had visited a local otolaryngologic clinic 2 months previously. At
the local clinic, she was diagnosed with acute otitis media and was
administered empirical oral antibiotics (amoxicillin 500 mg four
times a day) for 1 week. Because the otalgia and otorrhea persisted,
she visited another otolaryngology clinic for a second opinion,
where shewas diagnosedwith acute otitis media and otitis externa.logy, En Chu Kong Hospital,
37, Taiwan. Tel.: þ886 2 2672
W. Chen).
ddhist Compassion Relief Tzu ChiEmpirical oral antibiotics (amoxicillin and clabulanate potassium
[Augmentin] 1 g two times a day) and ototopical drops (oﬂoxacin)
were prescribed for 4 weeks. However, the otorrhea and otalgia,
which were accompanied by headache, became more severe, and
necrotizing otitis externa was suspected. Therefore, she was
referred to our hospital for further evaluation and treatment.
Her medical history was unremarkable, and she was afebrile
without any neurological deﬁcit. The right external ear canal was
injected and swollen with a purulent discharge. The ear discharge
was thick and cheesy, and some pepper-like colonies were
observed in the external ear canal. We also observed granulation
tissue and bony destruction in the posterior wall of the external ear
canal along with 20% perforation of the tympanic membrane
(Fig. 1). Pure tone audiometry showed right conductive hearing loss
(air-bone gap: 25 dB). High-resolution computed tomography scan
of the temporal bone (Fig. 2) revealed increased soft tissue in the
right middle ear cavity and the external ear canal.
The diagnosis of necrotizing otitis externa was made and we
administered empirical intravenous antibiotics (amoxicillin and
clabulanate potassium [Augmentin] 1200 mg every 8 hours and
gentamicin 160 mg once a day [qd]); however, these antibiotics
were discontinued 3 days later because the culture of the discharge
yielded fungi instead of bacteria. However, the deﬁnite fungus
species could not be identiﬁed initially in our laboratory. We per-
formed a biopsy of the granulation tissue in the right external ear
canal to rule out malignancy, and pathological examination
revealed ﬁbrous tissue with moderate inﬁltration of lymphocytes.
We administered oral ketoconazole (400 mg qd) on the basis of
a diagnosis of invasive otomycosis and performed daily clearing ofFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Granulation tissue and bony destruction in the posterior wall of the external ear
canal with 20% perforation of the tympanic membrane.
Fig. 3. Microscopic examination reveals condensed aggregation of vesicles and hyphal
forms of Aspergillus niger (1,000 oil immersion).
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subsided, and she was discharged 2 weeks later.
However, 3 days later, she was rehospitalized because of recur-
rent severe headache and otalgia. She again had an injected right
external ear canal with purulent and cheesy discharge and some
pepper-like colonies. The patient initially received intravenousFig. 2. CT scan of the temporal bone showing increased soft tissue in the right middle eaﬂuconazole (200 mg qd) and gentamicin (160 mg qd) for 3 days
after which these antibiotics were replaced by amphotericin B
(30 mg qd) and piperacillin and tazobactam (Tazocin) (2.25 g every
8 hours) for 4 days. The patient’s condition did not improve despite
the treatment, and the fungal culture yielded Aspergillus niger
(Fig. 3); therefore, we prescribed intravenous voriconazole (loading
dose, 300 mg every 12 hours for 1 day; maintenance dose, 200 mg
every 12 hours for 5 days), whereby her condition improved. Oral
voriconazole (200 mg two times a day) was administered for
another 5 days, and then the patient was discharged.r cavity, the external ear canal and the mastoid cavity. CT¼computed tomography.
Fig. 4. The right tympanic membrane with 20% perforation.
Table 1
Classiﬁcation of fungal infection of the ear and temporal bone by Chen et al. [2]
Type Extent of the disease
I Limited otitis externa
II Otitis externa with extension into the mastoid cavity/mastoiditis
III Invasive mastoiditis with nerve VII palsy
IV Invasive mastoiditis, nerve VII palsy, and skull base osteomyelitis
C.-L. Hsu et al. / Tzu Chi Medical Journal 23 (2011) 66e6868The patient did not develop headache, otalgia, or otorrhea
subsequently, but 20%perforation of the right tympanicmembrane
was still observed (Fig. 4). The patient underwent a Type I tym-
panoplasty 3 months later, and the postoperative course was
uneventful.
3. Discussion
Otomycosis, also known as fungal otitis externa, is a fungal
infection of the external auditory canal, and it commonly develops in
hot humid climates, such as that found in Taiwan. The diagnosis of
otomycosis is based on common presenting symptoms, including
otalgia, otorrhea, and pruritus [1] and local examination ﬁndings,
including an injected external ear canalwith aﬂuffywhite discharge.
The treatment involves cleaning of secretions and debris in combi-
nation with application of topical antifungal agents. Cultures of the
discharge are not routinely obtained because patients generally
respond rapidly to treatment. Nevertheless, in cultures, Aspergillus
and Candida are the most common fungal species isolated.
Otomycosis rarely results in serious complications. Chen et al.
[2] classiﬁed fungal infections of the ear and temporal bone infec-
tions into four types according to extension of the disease process
and treatment (Table 1).
The predisposing factors in invasive fungal infection include
immunocompromised status, malignant neoplasms, and increased
use of steroids and wide-spectrum antibiotics [3,4]. Widespread
use of ototopical antibiotics has become a major concern because
they may increase the risk of otomycosis [1,4,5]. Physicians often
choose oﬂoxacin eardrops as the ﬁrst-line therapy for otitis media
and otitis externa because common pathogens can be eliminated
with this treatment. However, oﬂoxacin may alter the homeostasis
maintained by the normal ﬂora in the external ear canal [4]. The
recurrent and prolonged use of oﬂoxacin eardrops (pH 7), which
changes the normal acidic environment of the external ear canal
(pH 3e4), may lead to fungal proliferation and suppress the growth
of competing bacteria, thereby contributing to a more severe
bacterial infection or fungal proliferation.
In our patient, bacterial otitis externa was initially suspected at
the other otolaryngologic clinics, but the patient showed a poor
response to treatment. We hypothesize that otomycosis was not
diagnosed at any of the previous clinics. Furthermore, theprolonged treatment with oﬂoxacin eardrops may have led to an
invasive fungal infection. Furthermore, during the ﬁrst hospitali-
zation, the patient had a good response to oral ketoconazole
treatment in the ﬁrst 2 weeks. We presume that the use of keto-
conazole masked the symptoms and the signs of invasive otomy-
cosis. It may be the reason why she was rehospitalized 3 days later
when she stopped oral ketoconazole. In addition, the main patho-
genetic species of A niger is resistant to general antifungal agents
but is sensitive to voriconazole.
To date, the common antifungal agents for the treatment of
otomycosis include cresylate otic drops and topical azole antifungal
agents (ﬂuconazole, ketoconazole, and clotrimazole) [1,5]. However,
recent reports have shown an increase in fungal resistance to these
agents in vitro [6,7]. Because our patient showed a poor response to
systemic ketoconazole, ﬂuconazole, and amphotericin B, we chose
voriconazole,which is used for the treatment of serious and invasive
fungal infections [8]. Her clinical condition improved after admin-
istration of systemic voriconazole.
In Taiwan, oﬂoxacin eardrops arewidely used in otolaryngology
clinics for the treatment of otorrhea. Some clinics even prescribe
eardrops containing steroids for the treatment of pruritus. Because
our patient was immunocompetent and had not undergone
surgery, we presume that the delayed diagnosis of otomycosis and
the prolonged use of ﬂuoroquinolone ototopical drops may have
contributed to the iatrogenic and invasive fungal infection. Subse-
quently, the disease became invasive and extended to the middle
ear cavity, and the pathogen developed resistance to general anti-
fungal agents. In conclusion, it is emphasized that ototopical anti-
biotics be used cautiously by otolaryngology clinics. If persistent
otorrhea is detected, especially after treatment with ototopical
antibiotic agents, otomycosis should be considered. If otomycosis is
diagnosed, then the fungal agent should also be identiﬁed as soon
as possible, and optimal antifungal treatment must be given
immediately.
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